High Altitude Task Force

Back to Task Forces & IDDI Workstreams
High altitude task force image

More than 80 million people worldwide live in high altitude areas (>2500 metres above sea level). Studies indicate that factors linked to high altitude including low oxygen levels, vasculopathy and metabolic abnormalities alongside genetic predispositions, collectively contribute to the onset and advancement of PH. 

The Task Force brings together researchers worldwide with an interest in the effects of hypoxia and high altitude on the pulmonary vasculature and related physiology. It raises awareness and understanding of pulmonary hypertension (PH) linked to high altitude and organises scientific conferences in high-altitude affected regions.


 

Webinars

The Task Force is organising a series of webinars on Hypoxia in pulmonary vascular research – altitude and beyond. 

Upcoming webinars

Past webinar recordings


 

Events

Upcoming events

 

Past recordings

  • Satellite Meeting at PVRI Dublin 2026
    The High Altitude Task Force held a satellite meeting at the most recent PVRI Congress in Dublin. The session explored the pathophysiology, clinical impact, and management of pulmonary hypertension at high altitude.
    Watch the recordings here 

 

Publications

 

Leaders

Aastha Mishra, Institute of genomics and integrative biology (CSIR), India
Silvia Ulrich, University Hospital of Zurich, Switzerland